LEADER 05277nam 22007815 450 001 9910300203703321 005 20200702151451.0 010 $a3-319-13126-5 024 7 $a10.1007/978-3-319-13126-9 035 $a(CKB)3710000000325011 035 $a(EBL)1965409 035 $a(OCoLC)908083409 035 $a(SSID)ssj0001408331 035 $a(PQKBManifestationID)11797480 035 $a(PQKBTitleCode)TC0001408331 035 $a(PQKBWorkID)11346800 035 $a(PQKB)11715494 035 $a(DE-He213)978-3-319-13126-9 035 $a(MiAaPQ)EBC1965409 035 $a(PPN)183149653 035 $a(EXLCZ)993710000000325011 100 $a20141229d2015 u| 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 10$aObesity and Diabetes $eNew Surgical and Nonsurgical Approaches /$fedited by Joel Faintuch, Salomão Faintuch 205 $a1st ed. 2015. 210 1$aCham :$cSpringer International Publishing :$cImprint: Springer,$d2015. 215 $a1 online resource (286 p.) 300 $aDescription based upon print version of record. 311 $a3-319-13125-7 320 $aIncludes bibliographical references. 327 $aThe Dual Problem of Obesity and Diabetes: Old Problems Die Hard -- Cost of Obesity Recurrence -- Recent Trends in Bariatric and Metabolic Surgery -- Perspectives of Robotic Bariatric Surgery -- Sleeve Gastrectomy and Transit Bipartition -- Surgical Options in Type 2 Diabetes -- Endoscopic Therapeutic Options for Type 2 Diabetes -- Ileal Transposition Surgery: Mechanisms of Weight Loss and Diabetes Improvements -- Left Gastric Artery Embolization to Treat Obesity: Rationale, Technique, Experimental and Clinical Studies -- Pharmacologic Approach to Type 2 Diabetes in Obese Patients -- Peripheral Signals and Food Intake Control -- Appetite-Inhibiting Properties of Proteins -- Cell Therapy for Diabetes -- Stem Cells Derived Insulin-Secreting Cells for Insulin-Dependent Diabetes Mellitus: Exploiting Laboratory Discoveries. 330 $aThis timely and clinically oriented book uniquely addresses the entire spectrum of treatment for severe obesity and diabetes. It thoroughly examines all aspects from robotic surgery to cell therapy, from the latest antidiabetic drugs to endoscopic procedures and devices, from appetite-inhibiting signals and nutrients to gastric arterial embolization. It offers objective and authoritative information for practicing professionals; not only are successful interventions discussed and updated, but cutting-edge and experimental pathways are also anticipated. Obesity is the foremost nutritional challenge worldwide. Its companion is type-2 diabetes, the most prevalent metabolic disease. Together they represent the diabesity epidemic, which is draining resources, overwhelming healthcare facilities, and impacting life expectancy and quality of life everywhere. No country has been spared, and most medical specialties have been affected. Many books focus on the surgical options for obesity and diabetes, namely bariatric and metabolic operations. Information on the clinical and pharmacological treatment is also available, conveyed by standard texts on internal medicine and endocrinology. Yet endoscopic maneuvers and prostheses, cell therapy for diabetes, and other innovative approaches are hard to come by, as conventional texts overlook such therapies. This timely publication bridges the gaps between all different therapeutic options, also covering advances in the conservative, surgical and parasurgical domains. This book will appeal to seasoned specialists, students and healthcare professionals in training alike. 606 $aMetabolic diseases 606 $aDiabetes 606 $aMinimally invasive surgery 606 $aHuman physiology 606 $aEndocrinology  606 $aCancer research 606 $aMetabolic Diseases$3https://scigraph.springernature.com/ontologies/product-market-codes/H33118 606 $aDiabetes$3https://scigraph.springernature.com/ontologies/product-market-codes/H33045 606 $aMinimally Invasive Surgery$3https://scigraph.springernature.com/ontologies/product-market-codes/H59052 606 $aHuman Physiology$3https://scigraph.springernature.com/ontologies/product-market-codes/B13004 606 $aEndocrinology$3https://scigraph.springernature.com/ontologies/product-market-codes/H33053 606 $aCancer Research$3https://scigraph.springernature.com/ontologies/product-market-codes/B11001 615 0$aMetabolic diseases. 615 0$aDiabetes. 615 0$aMinimally invasive surgery. 615 0$aHuman physiology. 615 0$aEndocrinology . 615 0$aCancer research. 615 14$aMetabolic Diseases. 615 24$aDiabetes. 615 24$aMinimally Invasive Surgery. 615 24$aHuman Physiology. 615 24$aEndocrinology. 615 24$aCancer Research. 676 $a617.9 676 $a617.952 702 $aFaintuch$b Joel$4edt$4http://id.loc.gov/vocabulary/relators/edt 702 $aFaintuch$b Salomão$4edt$4http://id.loc.gov/vocabulary/relators/edt 906 $aBOOK 912 $a9910300203703321 996 $aObesity and diabetes$92139680 997 $aUNINA